ABBVIE INC. vs. Ironwood Pharmaceuticals, Inc. - Class A
ABBVIE INC. (ABBV) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| ABBV | IRWD | |
|---|---|---|
| Market Cap | $451.46 billion | $682.44 million |
| Revenue (TTM) | $64.39 billion | $389.32 million |
| Net Income (TTM) | $6.32 billion | $129.87 million |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | IRWD | |
|---|---|---|
| P/E Ratio | 72.44 | 5.52 |
| Price / Book | -76.68 | -4.22 |
| Price / Sales | 7.01 | 1.75 |
IRWD leads on 2 of 3 valuation factors.
Profitability
| ABBV | IRWD | |
|---|---|---|
| Net Margin | 9.81% | 33.36% |
| Return on Equity | -107.29% | -80.24% |
IRWD leads on 2 of 2 profitability factors.
Dividend
| ABBV | IRWD | |
|---|---|---|
| Dividend Yield | 2.70% | — |
| Payout Ratio | 195.48 | — |
ABBV and IRWD split the dividend factors evenly.
Risk & Sentiment
| ABBV | IRWD | |
|---|---|---|
| Short Interest | 0.85% | 11.02% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, IRWD overview, IRWD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
